OpenAlex Citation Counts

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel Design Strategies to Enhance the Efficiency of Proteolysis Targeting Chimeras
Chunlong Zhao, Frank J. Dekker
ACS Pharmacology & Translational Science (2022) Vol. 5, Iss. 9, pp. 710-723
Open Access | Times Cited: 16

Showing 16 citing articles:

Targeted protein degradation directly engaging lysosomes or proteasomes
Jiseong Kim, Insuk Byun, Do Young Kim, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 7, pp. 3253-3272
Open Access | Times Cited: 25

Drug Discovery Targeting Nuclear Receptor Binding SET Domain Protein 2 (NSD2)
Zonghui Ma, Andrew A. Bolinger, Haiying Chen, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 16, pp. 10991-11026
Open Access | Times Cited: 20

Targeted Protein Degradation for Infectious Diseases: from Basic Biology to Drug Discovery
Rocío Marisol Espinoza-Chávez, Alessandra Salerno, Anastasia Liuzzi, et al.
ACS Bio & Med Chem Au (2022) Vol. 3, Iss. 1, pp. 32-45
Open Access | Times Cited: 23

Discovery of highly potent HDAC8 PROTACs with anti-tumor activity
Chunlong Zhao, Deng Chen, Feng‐Zhi Suo, et al.
Bioorganic Chemistry (2023) Vol. 136, pp. 106546-106546
Open Access | Times Cited: 16

Click chemistry in the development of PROTACs
Ce Yang, Ravi Tripathi, Binghe Wang
RSC Chemical Biology (2023) Vol. 5, Iss. 3, pp. 189-197
Open Access | Times Cited: 14

Navigating PROTACs in Cancer Therapy: Advancements, Challenges, and Future Horizons
S.M. Ibrahim, Muhammad Umer Khan, Iqra Khurram, et al.
Food Science & Nutrition (2025) Vol. 13, Iss. 2
Open Access

Powering up targeted protein degradation through active and passive tumour-targeting strategies: Current and future scopes
Janarthanan Venkatesan, Dhanashree Murugan, Kalaiarasu Lakshminarayanan, et al.
Pharmacology & Therapeutics (2024) Vol. 263, pp. 108725-108725
Closed Access | Times Cited: 3

Histone Deacetylase 3‐Directed PROTACs Have Anti‐inflammatory Potential by Blocking Polarization of M0‐like into M1‐like Macrophages
Chunlong Zhao, Shipeng Chen, Deng Chen, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 42
Open Access | Times Cited: 8

Synthesis of selective BCL-XL PROTAC and potent antitumor activity in glioblastoma
Jinlong Yin, Biao Sun, Meichen Liu, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1

Delivering on Cell‐Selective Protein Degradation Using Chemically Tailored PROTACs
Rui Yao, Tianli Luo, Ming Wang
ChemBioChem (2023) Vol. 24, Iss. 19
Closed Access | Times Cited: 3

Targeted degrader technologies as prospective SARS-CoV-2 therapies
Rabia Khurshid, Joseph M. Schulz, Jiaming Hu, et al.
Drug Discovery Today (2023) Vol. 29, Iss. 1, pp. 103847-103847
Closed Access | Times Cited: 3

Novel biomolecules in targeted cancer therapy: a new approach towards precision medicine
Sandra Kannampuzha, Reshma Murali, Abilash Valsala Gopalakrishnan, et al.
Medical Oncology (2023) Vol. 40, Iss. 11
Closed Access | Times Cited: 2

Powering Up Targeted Protein Degradation Through Active and Passive Tumour-Targeting Strategies: Current and Future Scopes
Janarthanan Venkatesan, Dhanashree Murugan, Kalaiarasu Lakshminarayanan, et al.
(2024)
Closed Access

Revolutionizing lung cancer treatment: Introducing PROTAC therapy as a novel paradigm in targeted therapeutics
Atharva Anand Mahajan, Gauri Panzade, Tiyasa Bhuniya, et al.
Current Problems in Cancer (2024) Vol. 54, pp. 101172-101172
Closed Access

WITHDRAWN: Targeted protein degradation: A promising approach for cancer treatment
Muhammad Zafar Irshad Khan, Adila Nazli, Iffat Naz, et al.
Journal of Pharmaceutical Analysis (2023)
Open Access | Times Cited: 1

Page 1

Cookie	Duration	Description
cookielawinfo-checkbox-advertisement	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Analytics" category .
cookielawinfo-checkbox-functional	1 year	The cookie is set by the GDPR Cookie Consent plugin to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Necessary" category .
cookielawinfo-checkbox-others	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Others".
cookielawinfo-checkbox-performance	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Performance".
CookieLawInfoConsent	1 year	Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
PHPSESSID	session	This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.

Requested Article:

Showing 16 citing articles:

Your Privacy